LncEDCH1 improves mitochondrial function to reduce muscle atrophy by interacting with SERCA2

Area of Science:

• Molecular Biology
• Muscle Physiology
• Gene Regulation

Background:

• Skeletal muscle is crucial for energy metabolism, and its diseases stem from gene dysregulation.
• Long non-coding RNAs (lncRNAs) are implicated in muscle growth and atrophy.
• Identifying novel regulators like lncRNAs is vital for understanding and treating muscle disorders.

Purpose of the Study:

• To investigate the function of the muscle-associated long non-coding RNA, LncEDCH1.
• To explore LncEDCH1's role in myoblast proliferation, differentiation, and in vivo muscle function.
• To elucidate the molecular mechanisms underlying LncEDCH1's effects on muscle metabolism and atrophy.

Main Methods:

• RNA sequencing data analysis to identify muscle-associated lncRNAs.
• In vitro studies on myoblast proliferation and differentiation.
• In vivo studies assessing intramuscular fat, muscle phenotype, and atrophy.
• Mechanistic studies involving protein binding assays and pathway analysis (SERCA2, AMPK).

Main Results:

• LncEDCH1 is specifically enriched in skeletal muscle and regulated by SP1.
• LncEDCH1 promotes myoblast proliferation and differentiation in vitro.
• In vivo, LncEDCH1 reduces fat deposition, promotes slow-twitch fibers, and inhibits muscle atrophy.
• LncEDCH1 enhances SERCA2 protein stability and activity, improving mitochondrial efficiency via the AMPK pathway.

Conclusions:

• LncEDCH1 is a critical regulator of skeletal muscle homeostasis and metabolism.
• LncEDCH1's interaction with SERCA2 and activation of the AMPK pathway are key mechanisms.
• LncEDCH1 represents a potential therapeutic target for muscle atrophy and metabolic disorders.